<i>Staphylococcus aureus</i> subcapsular splenic abscess and associated empyema in the setting of tocilizumab therapy: A case report-Reference-Cited by-同舟云学术

Staphylococcus aureus subcapsular splenic abscess and associated empyema in the setting of tocilizumab therapy: A case report

Published:2024-05-24 Issue:6 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Lee Audrey¹^ORCID,Aw Yi Tong Vincent¹²³^ORCID

Affiliation:

1. General Medicine Department Canberra Hospital, Canberra Health Services Canberra Australian Capital Territory Australia

2. Australian National University Medical School, School of Medicine and Psychology Australian National University Canberra Australian Capital Territory Australia

3. John Curtin School of Medical Research, College of Health and Medicine Australian National University Canberra Australian Capital Territory Australia

Abstract

Key Clinical MessageWe report a case of Staphylococcus aureus subcapsular splenic abscess and associated empyema after recent commencement of tocilizumab, masquerading as musculoskeletal pain. This highlights the importance of considering unusual underlying infections in patients on tocilizumab.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8997

Reference10 articles.

1. Tocilizumab for rheumatoid arthritis

2. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

3. Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials

4. Three cases of severely disseminated Staphylococcus aureus infection in patients treated with tocilizumab

5. The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature